Skip to content
USPeptideRxLearnApply for an account

Compliance · State rules

Office-use compounding in Hawaii

Silent in both directions; non-patient-specific supply falls outside the prescription exclusion
USPeptideRx EditorialLast reviewed:

Hawaii has written no office-use provision and no office-use prohibition. The phrase does not appear in its pharmacy statutes or its pharmacy rules at all, so neither headline sentence about Hawaii is available. What can be said is narrower and more useful: Hawaii excludes from "wholesale distribution" the dispensing of a drug pursuant to a prescription, and non-patient-specific supply to a practitioner is not that — so it falls outside the exclusion rather than inside a permission. The one express channel for stock that is not tied to a named patient is the emergency-kit rule, and whether it reaches a private practice turns on a contradiction between a rule and its own enabling statute that has stood for two decades. This page publishes both texts and does not resolve it.

The governing rule

Hawaii’s office-use position is set by HRS § 328-112(6) and HAR § 16-95-2, with HAR § 16-95-81 (emergency kits). The text below is quoted verbatim; everything outside a quote block is our summary of it, and the two are kept visually separate on purpose.

HRS § 461-1 — "Institutional facility", as the legislature defines it
"Institutional facility" means an organization or facility whose primary purpose is to provide a physical environment for patients to obtain health care services or at-home care services, and that uses the services of an on-site pharmacy, an off-site pharmacy, or a pharmacist contractor at which medication storage is managed by personnel of the facility. "Institutional facility" includes but is not limited to a: (1) Hospital; (2) Convalescent home; (3) Skilled nursing facility; (4) Intermediate care facility; (5) Extended care facility; (6) Rehabilitation center; (7) Health maintenance organization clinic; (8) Psychiatric center; (9) Intellectual disability center; (10) Penal institution; (11) Hospice facility; (12) Supervised living group; or (13) Prescribing practitioner's office.
HAR § 16-95-2 — "Institutional facility", as the Board’s rule defines it, ending with the exclusion that creates the conflict
"Institutional facility" includes a: (1) Hospital; (2) Convalescent home; (3) Nursing home; (4) Extended care facility; (5) Mental institution; (6) Rehabilitation center; (7) Health maintenance organization; (8) Psychiatric center; (9) Mental retardation center; (10) Penal institution; or (11) Any other organization whose primary purpose is to provide a physical environment for patients to obtain health care services or at-home care services, except those places where physicians, dentists, veterinarians, osteopaths, podiatrists, or other prescribers who are duly licensed, engage in private practice.
HAR § 16-95-81(a) — the emergency-kit channel
A pharmacist may provide emergency kits to an institutional facility which does not have an institutional pharmacy to meet the immediate therapeutic needs of patients.
HRS § 328-112(6) — the exclusion from wholesale distribution, and how far it reaches
The sale, purchase, or trade of a drug, or an offer to sell, purchase, or trade a drug, or the dispensing of a drug, pursuant to a prescription;
HRS § 461-19 — the practitioner exemption
This chapter shall not apply to any practitioner legally licensed by the State or authorized by the laws of the State to prescribe prescription drugs within the scope of the practitioner’s practice when the practitioner is handling drugs in the course of the practitioner’s professional duties or prohibit the practitioner from personally supplying the practitioner’s own patients with such prescription drugs if the prescription drugs fall within the practitioner’s scope of authorized practice.
Act 278, Session Laws of Hawaii 2022, § 62 — the date the controlled-substance registrar changed (elision marked)
… Parts III, IV, V, and VIII shall take effect on January 1, 2024; …

What the rule requires in practice

Each item carries a confidence level. Verbatim rule text is high confidence; a reading of how two provisions interact, or a source that could not be re-verified, is not.

The silence is measured, not assumedHigh confidence
We searched the Board of Pharmacy’s own rules for "office use", "office stock", "outsourcing", "503B", "non-patient" and "patient-specific". Every one returns nothing. A control search for "pharmacist" in the same document returns well over a hundred hits, so the zeros are the document’s and not a broken search. Hawaii has legislated neither way.
What captures the transaction insteadMedium confidence
Hawaii’s definition of wholesale distribution excludes eight things, and the one that would matter here is narrow: the dispensing of a drug pursuant to a prescription. Supply of stock that is not tied to a named patient is not dispensing pursuant to a prescription, so it does not fall inside that exclusion. This is a definitional reading rather than a prohibition anyone has written, and it is offered as that.
The contradiction that decides Hawaii’s only express channelHigh confidence
The emergency-kit rule lets a pharmacist supply an institutional facility that has no institutional pharmacy. Everything turns on what that phrase covers, and Hawaii’s two instruments disagree. The statute lists a prescribing practitioner’s office as the last of its enumerated institutional facilities, and has done since 2004. The Board’s rule closes its own list by excluding places where licensed prescribers engage in private practice, and has been recompiled three times since the statute changed without that exclusion being touched.Both readings are defensible. On one, the rule governs its own grant and the emergency-kit provision cannot reach a private practice. On the other, a rule may not narrow a definition the legislature wrote, and a prescribing practitioner’s office is an institutional facility. Only the Board can settle this, and its minutes and declaratory rulings could not be reached.
If the emergency-kit route is open, it is heavily conditionedHigh confidence
It is not a general supply channel and it should not be read as one. The pharmacist and the facility’s medical staff jointly determine the drugs and the quantity; the exterior must be labelled as an emergency drug kit with a maintained list of contents, strengths, quantities and expiry dates plus the supplying pharmacy’s details; each drug inside carries its own identification requirements; the pharmacist replaces, relabels and reseals on or before the earliest expiry; and the facility must have written policies covering secure storage, removal only pursuant to a valid prescription or practitioner’s order, and notification to the pharmacist within twenty-four hours of any removal.
The five per cent clause here confers nothing on a practitionerHigh confidence
Hawaii’s percentage clause sits inside the same definition and is limited twice over: it reaches transfers of prescription drugs by a retail pharmacy to another retail pharmacy, and only to alleviate a temporary shortage, capped at five per cent of either party’s total prescription drug sales revenue over twelve consecutive months. It runs pharmacy to pharmacy. It is not authority for supplying a practitioner and it says nothing about compounding.
The definitions carrying all of this have not been touched since 1992High confidence
The section holding both the percentage clause and the prescription exclusion carries a single history stamp from 1992 and has never been amended. It predates the federal Drug Quality and Security Act entirely, which is worth knowing before reading its categories as though they were drawn with outsourcing facilities in mind. They were not.
Compounding standards enter only through a disciplinary groundHigh confidence
Hawaii has no compounding chapter as such. USP chapters 795 and 797 reach pharmacists through a single disciplinary provision — failing to comply with them is grounds for action, with fines from $100 to $1,000 per violation and each day capable of being treated separately. The incorporation is dynamic, reaching those chapters "as amended", so the standard stays current even though the rule is a decade old. USP 800 is not mentioned anywhere.
The practitioner exemption is about the practitioner, not about the supplyHigh confidence
Hawaii’s pharmacy chapter does not apply to a licensed practitioner handling drugs in the course of professional duties, and does not stop a practitioner personally supplying their own patients within their scope. Read what it does: it takes the practitioner out of the pharmacy chapter. It does not tell a pharmacy what it may ship, which is the question this page is about.
Last change, and one that is still mis-cited by the state itselfHigh confidence
The rules were last compiled in 2016. The most consequential recent change is on the controlled-substance side: registration moved to a newly created Department of Law Enforcement with effect from 1 January 2024. Anything naming the Department of Public Safety for this is out of date — including two of the Board of Pharmacy’s own application forms, which carry March 2024 revision stamps and still print the former agency’s name.

Hawaii at a glance

Hawaii office-use compounding summary, reviewed 2026-09-01
Human office useSilent both ways; the transaction falls outside the prescription exclusion
Sterile preparationsNo split in Hawaii law; USP 795 and 797 enter only as a disciplinary ground
Quantity capNone; the emergency kit’s quantity is jointly determined, not legislated
Mandatory label legendNone for office use; emergency kits carry their own exterior and per-item labels
Board reportingNone for office use
Last changeRules compiled 15 August 2016; controlled-substance registrar changed 1 January 2024
Governing ruleHRS § 328-112(6) and HAR § 16-95-2, with HAR § 16-95-81 (emergency kits)

Receiving 503B office stock in Hawaii

Hawaii has no outsourcing-facility category under any name, which does not mean no licence is needed — it means the credential is a general one, and whether a pure outsourcing facility can satisfy its conditions is an open question. Three separate agencies are involved and one of them changed identity recently.

Everything above this heading answers the supply question: may a state-licensed 503A pharmacy ship non-patient-specific stock? This section answers the other half. Registration with FDA under section 503B is a federal exemption from federal law and preempts no state licensing scheme, so it is never the whole answer on its own — a state credential is the norm rather than the exception, it is not always issued by the board of pharmacy, and in some states the category you would search for does not exist. What Hawaii asks for is set out below, including where we could not establish it.

What the 503B must hold to ship inLow confidence
Not established as a settled route, and the uncertainty is worth more to you than a confident answer. Hawaii has no outsourcing-facility licence class, so a facility is directed to a general Board permit. But the out-of-state permit provision conditions the permit on verification of a home-state licence, permit or registration to conduct the pharmacy, and on having a registered pharmacist in good standing in the applicant’s employ. A pure outsourcing facility is not a pharmacy, may hold no home-state pharmacy licence and may employ no pharmacist — so those conditions may be literally unsatisfiable. Ask the Board before assuming a route exists.
Does your practice need a permit?Medium confidence
For non-controlled drugs the pharmacy chapter does not reach a practitioner handling drugs in the course of professional duties, and we found no separate instrument imposing a receiving-side credential. For controlled substances the answer is different and is set out below.
Administer vs dispenseMedium confidence
Hawaii answers at the transaction rather than at the act. Its exclusion from wholesale distribution turns on dispensing pursuant to a prescription, so the classification of a shipment is decided before the practitioner does anything with it. What the practitioner then does matters for their own exemption, which covers supplying their own patients within their scope.
Scheduled (controlled) stockHigh confidence
Hawaii requires its own controlled-substance registration, and it comes before the federal one rather than after it. A separate registration is required at each principal place of business or professional practice, with an exemption for an office where controlled substances are prescribed but neither administered nor dispensed as a regular part of practice and where no supplies are kept — so a practice holding stock does not qualify for that exemption. The registrar is the Narcotics Enforcement Division of the Department of Law Enforcement.The wholesale licence has a second gate that is easy to miss: the Board’s rule provides that no licence shall issue before a satisfactory inspection report is received from the state Department of Health, whose Food and Drug Branch inspects the premises.

How to check a facility’s credential before you order is set out in how to place an office-use order.

The federal layer still applies

Whatever Hawaii law allows, federal law applies on top of it and is not satisfied by state permission. 21 U.S.C. § 353a conditions the federal compounding exemptions on a drug being compounded for an identified individual patient on receipt of a valid prescription order. A state rule cannot create a federal safe harbour, and several state rules say so in their own text. The separate federal pathway for non-patient-specific office stock is the 503B outsourcing facility — the differences are set out in 503A vs 503B.

For how Hawaii compares with the other states reviewed, see the state-by-state comparison.

What this page does not establish

  • This page does not tell you whether Hawaii permits or prohibits office use, because Hawaii has legislated neither. The reading that non-patient-specific supply falls outside the prescription exclusion is a definitional inference from the wholesale-distribution definition, and it is offered as an inference rather than as a rule anyone can cite.
  • The emergency-kit question is deliberately left open. The Board’s rule excludes places where licensed prescribers engage in private practice from "institutional facility"; the legislature’s own definition includes a prescribing practitioner’s office. Both texts are quoted above. Only the Hawaii Board of Pharmacy can settle which governs, and this page will not do it for them — the answer decides whether Hawaii has any lawful non-patient-specific channel to a private practice at all.
  • The Board’s minutes, declaratory rulings and proposed rulemaking could not be retrieved. A rate limiter shared across unrelated Hawaii government sites refused every attempt, so the one place the contradiction above might already have been resolved has not been read.
  • Fee amounts for Hawaii permits and controlled-substance registrations are not published here. The figures available to us came from application forms rather than from a fee rule, the fee rule itself is an image-only scan that yields no readable text, and we would rather report nothing than report a number we could not verify against the instrument that sets it.
  • Whether the Board will in practice issue a permit to a nonresident outsourcing facility, given the home-state pharmacy licence and employed-pharmacist conditions, is beyond the scope of this page and is not answerable from published text.
  • We searched no case law, attorney-general opinions or disciplinary orders for this state, and search engines were unavailable when it was researched. Read nothing into that silence — it means we have not looked, not that nothing is there.

Sources

Primary sources, fetched directly from the issuing body. No secondary summaries.

  1. [1]HRS § 461-1 — definitions, incl. "Institutional facility" and its thirteenth item
  2. [2]HAR Title 16 ch. 95 — Board of Pharmacy rules, incl. § 16-95-2 (definitions), § 16-95-81 (emergency kits) and § 16-95-110 (discipline)
  3. [3]HRS § 328-112 — definitions for wholesale distribution, incl. the five per cent clause and the prescription exclusion
  4. [4]HRS § 461-19 — application of the pharmacy chapter to practitioners
  5. [5]21 U.S.C. § 353a — Pharmacy compounding (Cornell LII)
  6. [6]HRS § 461-15 — permits, incl. (a)(6) and the out-of-state pharmacy permit conditions at (a)(7)
  7. [7]Act 278, Session Laws of Hawaii 2022 — the transfer of the Narcotics Enforcement Division, effective 1 January 2024